1. [DT‐02–02]: IDALOPIRDINE, A 5‐HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER's DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM. (1st July 2017) Authors: Atri, Alireza; Frölich, Lutz; Ballard, Clive; Tariot, Pierre; Molinuevo, José Luis; Boneva, Neli; Windfeld, Kristian; Cummings, Jeffrey L. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 30 Page Start: P1476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O3–06–01: A clinical phase II study of Lu AE58054 added to stable donepezil treatment in patients with moderate Alzheimer's disease. (1st July 2013) Authors: Wilkinson, David; Colding‐Jørgensen, Eskild; Windfeld, Kristian Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 13 Page Start: P529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1‐056: Idalopirdine, A 5‐HT6 Antagonist in Phase III Development as Adjunctive Therapy to Cholinesterase Inhibitors in Patients with Mild‐to‐Moderate Alzheimer's Disease: Baseline Data from the Ongoing Starshine Study. (1st July 2016) Authors: Atri, Alireza; Boneva, Neli; Cummings, Jeffrey L.; Frölich, Lutz; Tariot, Pierre N.; Windfeld, Kristian Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 8 Page Start: P423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial. Issue 3 (March 2019) Authors: de Bono, Johann S; Concin, Nicole; Hong, David S; Thistlethwaite, Fiona C; Machiels, Jean-Pascal; Arkenau, Hendrik-Tobias; Plummer, Ruth; Jones, Robert Hugh; Nielsen, Dorte; Windfeld, Kristian; Ghatta, Srinivas; Slomovitz, Brian M; Spicer, James F; Yachnin, Jeffrey; Ang, Joo Ern; Mau-Sørensen, Pa... Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗